JPH08322926A - Bioimplant - Google Patents

Bioimplant

Info

Publication number
JPH08322926A
JPH08322926A JP7133554A JP13355495A JPH08322926A JP H08322926 A JPH08322926 A JP H08322926A JP 7133554 A JP7133554 A JP 7133554A JP 13355495 A JP13355495 A JP 13355495A JP H08322926 A JPH08322926 A JP H08322926A
Authority
JP
Japan
Prior art keywords
ceramics
bioimplant
yag
yttria
implant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7133554A
Other languages
Japanese (ja)
Other versions
JP3261009B2 (en
Inventor
Toshikazu Kishino
敏和 岸野
Shunichi Murakawa
俊一 村川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyocera Corp
Original Assignee
Kyocera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyocera Corp filed Critical Kyocera Corp
Priority to JP13355495A priority Critical patent/JP3261009B2/en
Publication of JPH08322926A publication Critical patent/JPH08322926A/en
Application granted granted Critical
Publication of JP3261009B2 publication Critical patent/JP3261009B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE: To reduce a stimulus on nerve tissue and enable penetration during operation by forming a bioimplant by ceramics mainly composed of crystals of yttria, aluminium and garnet so that as X-ray impermeability is large, imaging is clear. CONSTITUTION: For example, a first member 1 and a second member 2 of a hinge-type artificial interphalangeal joint F as a bioimplant are formed by yttria-aluminium-garnet(YAG) ceramics. A joint 2 for connecting the first member and the second member to each other in such a manner as to freely rotate is formed by synthetic resin such as polyethylene or the like. In this arrangement, the first and second members 1, 2 formed by YAG ceramics have good workability and the members can be after-worked into a suitable form according to the form of a bone marrow cavity. Accordingly, looseness to the bone can be prevented. Further, the sliding ability is good, and the abrasion loss of the hinge part is small so that it is possible to prevent a bad influence upon a living body due to abrasion.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明はセラミックスからなる歯
科用インプラント、或いは整形用骨内インプラント等の
生体インプラントに関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a biomedical implant such as a dental implant made of ceramics or an orthopedic intraosseous implant.

【0002】[0002]

【従来の技術】従来より、人体の硬組織内に人工材料よ
りなるインプラントを埋入する治療法が用いられてい
る。
2. Description of the Related Art Conventionally, there has been used a treatment method of implanting an implant made of an artificial material in a hard tissue of a human body.

【0003】例えば、歯科用インプラントでは、病気、
疾病、事故等により脱落した歯牙を人工歯で置換するた
めに、顎骨内にインプラントを埋入植立し、この上部に
人工歯冠を装着するようになっている。このような歯科
用インプラントでは、 コバルト・クロム合金、チタン合金、鉄・ニッケル・
クロム合金などの金属材料、 単結晶サファイア、ハイドロキシアパタイトなどのセ
ラミックス材料などが用いられている。しかしの金属
材料は、体液や血液などで金属がイオン化され、生体の
軟組織に悪影響を与えることが多い。近年このような点
から生体内で安定なのようなセラミックスが使われる
ことが多くなっているが、術後に医療用のX線を透過す
ることから特公昭51−39654等で示される通りア
ルミナにY 2O3 等の添加物を加えてX線の非透過性を付
与することが試みられてきた。
For example, in dental implants, illness,
In order to replace a tooth that has fallen due to a disease, accident, or the like with an artificial tooth, an implant is implanted in the jawbone and an artificial crown is attached to the upper part of the implant. Such dental implants include cobalt / chromium alloys, titanium alloys, iron / nickel /
Metallic materials such as chromium alloys, ceramic materials such as single crystal sapphire and hydroxyapatite are used. However, such metal materials are often ionized by body fluids or blood, which adversely affects the soft tissues of the living body. In recent years, ceramics that are stable in the living body have been used in many cases from this point of view, but since they transmit X-rays for medical use after surgery, alumina is used as shown in JP-B-51-39654. Attempts have been made to add X-ray opacity by adding additives such as Y 2 O 3 .

【0004】[0004]

【従来技術の課題】しかしながら、上記従来技術には以
下のような問題点があった。すなわち、Y 2O3 等を添加
した従来のアルミナにおいて、Y 2O3 の添加量が少なか
ったのでX線非透過性が低く、造影が不十分であった。
However, the above-mentioned prior art has the following problems. That is, in the conventional alumina containing Y 2 O 3 or the like, the amount of Y 2 O 3 added was small, so that the X-ray opacity was low and the contrast was insufficient.

【0005】また従来のセラミック製インプラント材料
はいずれも難削材であり、ねじを形成したり、後加工で
寸法や形状を微調整するのが容易でないという問題点が
あった。
Further, all of the conventional ceramic implant materials are difficult-to-cut materials, and there is a problem that it is not easy to form a screw and to finely adjust the size and shape by post-processing.

【0006】その他、熱伝導率が大きめであったので、
例えば歯科インプラントの場合、熱い飲み物や食べ物を
口に入れた時に神経組織への刺激が大きいという不具合
があり、さらに不透明な材料であるので、術中に患部を
透視できず、視野が充分確保できないことがあった。
Besides, since the thermal conductivity was rather large,
For example, in the case of dental implants, when hot drinks or foods are put into the mouth, there is a problem that irritation to nerve tissue is large, and since it is an opaque material, it is not possible to see through the affected area during surgery and it is not possible to secure a sufficient visual field was there.

【0007】[0007]

【課題を解決するための手段】上記のような従来技術の
課題を解決するため、本発明はイットリア・アルミニウ
ム・ガーネットの結晶を主体とするセラミックスにより
構成した部材を具備してなる生体インプラントを提供す
るものである。
In order to solve the above-mentioned problems of the prior art, the present invention provides a bioimplant comprising a member composed of ceramics mainly composed of yttria-aluminum-garnet crystals. To do.

【0008】また、本発明の生体インプラントにおい
て、加工性と強度のバランスを保ち、さらに摺動性を良
くするため上記イットリア・アルミニウム・ガーネット
の結晶を主体とするセラミックスの平均粒子径を3〜1
00μm の範囲とした。
Further, in the bioimplant of the present invention, in order to maintain the balance between workability and strength and further improve slidability, the average particle size of the ceramics mainly composed of yttria-aluminum-garnet crystals is 3 to 1
The range was 00 μm.

【0009】[0009]

【作用】本発明の生体インプラントは、所望部材をイッ
トリア・アルミニウム・ガーネット(以下、YAGと略
称する)の結晶を主体とするから構成したことにより、 Y 2O3 を含有量するのでX線非透過性が大きいので造
影が明瞭となる、 熱伝導率が小さく、神経組織への刺激が少ない、 透明度を持たせれば、術中に患部を透視できる、 加工性が良く、異型品の制作も可能である、という作
用を有する。
[Action] biological implant of the present invention, the desired member yttria aluminum garnet (hereinafter, referred to as YAG) With the arrangements because mainly of crystals, X-ray because the content of Y 2 O 3 Because of its high transparency, the contrast is clear, the thermal conductivity is low, the nerve tissue is not stimulated, and if it has transparency, the affected area can be seen through during surgery. There is an action.

【0010】また、YAGセラミックスは加工性が非常
に良く、例えばねじ式の人工歯根のねじ部分を加工した
り異型加工が容易であるが、粒子径を3〜100μm と
小さい範囲としたことにより、強度も比較的大きく保た
れている。そして粒子径が3〜100μm の範囲と小さ
くすれば摺動性も良い。
Further, YAG ceramics have very good workability, and for example, it is easy to process the screw part of a screw type artificial tooth root and to perform atypical processing. However, by setting the particle diameter to a small range of 3 to 100 μm, The strength is also kept relatively high. If the particle size is reduced to the range of 3 to 100 μm, the slidability is good.

【0011】なお、上記YAGセラミックスは、多結
晶、単結晶のどちらでも構わない。
The YAG ceramics may be either polycrystal or single crystal.

【0012】[0012]

【実施例】以下、本発明の実施例を詳細に説明する。図
1は、本発明の生体インプラントとしてのヒンジ型の人
工指関節Fを示す。
EXAMPLES Examples of the present invention will be described in detail below. FIG. 1 shows a hinge type artificial finger joint F as a biological implant of the present invention.

【0013】第1部材1、第2部材2はともに上述のよ
うなYAGセラミックスから構成され、これら第1部材
および第2部材を回動自在に連結するジョイント2はポ
リエチレンなどの合成樹脂よりなる。
The first member 1 and the second member 2 are both made of YAG ceramics as described above, and the joint 2 for rotatably connecting the first member and the second member is made of synthetic resin such as polyethylene.

【0014】この人工指関節Fは、YAGセラミックス
からなる第1部材1、第2部材2の加工性が良いことか
ら骨髄腔の形状に合わせて部材を適宜形状に後加工でき
骨との緩みを未然に防止することができる。また慴動性
も良好であることからヒンジ部分の摩耗量も少なく摩耗
粉による生体への悪影響を防ぐことができる。
In this artificial finger joint F, since the first member 1 and the second member 2 made of YAG ceramics have good workability, the member can be post-processed into an appropriate shape according to the shape of the medullary cavity to loosen the bone. It can be prevented. In addition, since the slidability is also good, the amount of wear of the hinge portion is small, and the adverse effect of wear particles on the living body can be prevented.

【0015】図2は、本発明の生体インプラントしてY
AGセラミックスからなる歯科インプラントDを示し、
この歯科インプラントDは円柱状のポスト部Pの下方の
歯根部Sにダイヤモンド工具を用いてネジ溝Nを後加工
によって容易に形成したものであり、また透光性である
ことから術中の患部の様子が材料を透かしてみることも
でき、患者の患部の形状に応じた形状に容易に後加工で
きること、或いは熱伝導率が小さい為に熱などの刺激が
神経組織に伝わりにくく例えば、歯科用インプラント等
において熱い飲み物や食品を口に入れた時に歯にしみる
ような刺激を少なくすることが出来る等の特徴を有して
いる。
FIG. 2 shows a bioimplant of the present invention, which is Y
Shows a dental implant D made of AG ceramics,
This dental implant D is one in which a thread groove N is easily formed by post-processing using a diamond tool in a tooth root portion S below a columnar post portion P, and it is transparent, so It is possible to see the situation through the material, and it is easy to post-process it into a shape according to the shape of the affected part of the patient, or because the thermal conductivity is small, it is difficult for heat and other stimuli to be transmitted to nerve tissue. Etc., it has the feature that when a hot drink or food is put in the mouth, the irritation such as bleeding in the teeth can be reduced.

【0016】実験例1 重量パーセントで酸化アルミニウム42.9%と酸化イ
ットリウム57.1%を混合し、水を加え粉砕、平均粒
度(D50)を2.0μm 以下とした後に、バインダー
を加え攪拌、スプレードライヤーにて造粒した。この顆
粒を1000〜1400℃で仮焼した後、再度粉砕を行
いバインダーを加えてスラリーとしスプレードライヤー
にて造粒した。この造粒体を金型プレスにて成形した
後、真空炉にて1600℃〜1850℃にて、真空中で
焼成しYAGセラミックスを得た。
Experimental Example 1 4 % by weight of aluminum oxide and 57.1% of yttrium oxide were mixed in a weight percentage of 1 and water was added to pulverize the mixture so that the average particle size (D50) was 2.0 μm or less, and then a binder was added and stirred. Granulated with a spray dryer. The granules were calcined at 1000 to 1400 ° C., then pulverized again, and a binder was added to form a slurry, which was granulated by a spray dryer. The granulated body was molded by a die press and then fired in a vacuum furnace at 1600 ° C to 1850 ° C in a vacuum to obtain YAG ceramics.

【0017】出来上がったYAGセラミックスは一般的
に透光性を有する。しかしながら必ずしも透光性は要件
ではない。又、本成形においては金型プレスで成形して
いるが、例えばラバープレスなどの成形法を用いても良
いし、或いは鋳込み成形法など一般的セラミックスの成
形法を使用することも可である。作製した試料の諸特性
を計測すると表1の如くであった。
The finished YAG ceramics are generally transparent. However, translucency is not always a requirement. Further, in the main molding, the molding is performed by a die press, but a molding method such as a rubber press may be used, or a general ceramics molding method such as a cast molding method may be used. Table 1 shows the measured properties of the prepared sample.

【0018】[0018]

【表1】 [Table 1]

【0019】この表はYAGと99.9%アルミナを比
較したものであるが、曲げ強度は若干アルミナに比べ劣
るものの実用上問題ない領域でありビッカース硬度が低
い為に焼結後の異型への加工がアルミナに比べ容易であ
り、さらに熱伝導率が小さい為に熱などの刺激が神経組
織に伝わりにくく例えば、歯科用インプラント等におい
て冷凍品や熱い食品を食べた時に歯にしみるような刺激
を少なくすることが出来る。又耐薬品性も、硫酸、硝酸
に対しほぼ同等レベルであり、耐カ性ソーダに対しては
1桁違う耐性を有している。
This table compares YAG with 99.9% alumina, and although the bending strength is slightly inferior to that of alumina, it is in a practically unproblematic region and the Vickers hardness is low. It is easier to process than alumina, and its thermal conductivity is small, so it is difficult for heat and other stimuli to be transmitted to nerve tissue.For example, when dental foods such as dental implants are eaten with frozen products or hot foods, they cause irritation to the teeth. Can be reduced. Also, the chemical resistance is almost the same level for sulfuric acid and nitric acid, and has a resistance that is different by one digit for soda resistant soda.

【0020】さらに単結晶サファイアのようい透光性を
もたせることも可能であり、術中の患部の様子が材料を
透かしてみることもできる。また、開気孔のボイドを焼
結条件を変えることにより多くすることもでき、それほ
ど材料強度の必要がないところでは生体組織との結合を
強化することができる。
Further, it is possible to impart a translucency like single crystal sapphire, and the state of the affected area during the operation can be seen through the material. Further, the voids in the open pores can be increased by changing the sintering conditions, and the bond with the biological tissue can be strengthened where the material strength is not so required.

【0021】実験例2 実施例1のYAGセラミックスの製造方法において、焼
成温度及びキープ時間を表2に示すように変えて、表2
に示すような平均粒子径のセラミックスからなる円柱状
の歯科インプラントを作成した。
Experimental Example 2 In the method for producing the YAG ceramics of Example 1, the firing temperature and the keeping time were changed as shown in Table 2, and Table 2
A columnar dental implant made of ceramics having an average particle size as shown in was prepared.

【0022】[0022]

【表2】 [Table 2]

【0023】これらの歯科インプラントについて、まず
ビッカース硬度と曲げ強度を測定した。その結果を表2
に示す。
Vickers hardness and bending strength of these dental implants were first measured. The results are shown in Table 2.
Shown in

【0024】また、上記歯科インプラントについて、円
柱の下端部周囲にダイヤモンド工具によってねじ切り加
工を行い図2に示すような歯科インプラントDを作製し
た、その加工し易さを肉眼で観察し評価した。その結果
を表2に示す。
The dental implant was threaded around the lower end of the cylinder with a diamond tool to prepare a dental implant D as shown in FIG. 2. The easiness of processing was visually observed and evaluated. The results are shown in Table 2.

【0025】さらに、この歯科インプラントDを軸中心
に回転させ、その上端面を固定した板状の高分子ポリエ
チレンに摺動させた。これを長時間続け、高分子ポリエ
チレン板側の摩耗状況を肉眼で観察した。その結果を表
2に示す。
Further, this dental implant D was rotated about its axis and slid on a plate-shaped high-molecular polyethylene whose upper end surface was fixed. This was continued for a long time, and the state of wear on the side of the high-molecular polyethylene plate was visually observed. The results are shown in Table 2.

【0026】なお、最後の慴動性実験は、歯科インプラ
ントDに必要な特性を確認するためのものではないが、
例えば人工指関節Fなどに本発明の材料を用いた場合の
ヒンジ結合部分での慴動性がどのようになるかを推測す
るためのものであった。
Although the last slidability experiment is not for confirming the characteristics required for the dental implant D,
For example, the purpose was to estimate what the slidability of the hinge joint part would be when the material of the present invention was used for the artificial finger joint F and the like.

【0027】表2から明らかなように、YAGセラミッ
クスの平均粒径が3μm 〜100μm の場合、強度、加
工性、慴動性ともに良好であり、そのうち5μm 〜30
μmの場合が強度等の点を総合的に考えて結果が特に良
かった。これに対して平均粒径が3μm より小さい場
合、加工性に難があり、他方平均粒径が100μm より
大きいと強度と慴動性があまり良くなかった。
As is clear from Table 2, when the average particle size of the YAG ceramics is 3 μm to 100 μm, the strength, workability and slidability are all good, of which 5 μm to 30 μm.
In the case of μm, the result was particularly good considering the strength etc. comprehensively. On the other hand, if the average particle size is smaller than 3 μm, the workability is poor, while if the average particle size is larger than 100 μm, the strength and slidability are not so good.

【0028】以上より、本発明の生体インプラントを構
成するYAGセラミックスの平均粒径としては3μm 〜
100μm が望ましく、その中でも特に5〜30μm が
より好ましいことが判った。
From the above, the average particle size of the YAG ceramics constituting the biological implant of the present invention is 3 μm
It has been found that 100 [mu] m is desirable, and in particular, 5-30 [mu] m is more desirable.

【0029】なお、本発明は上記実施例に限定されるも
のではなく、人工足関節、人工肩関節、骨螺子、人工頭
蓋骨、生体端子としての生体内外開通部材などの生体イ
ンプラントをも構成することができる。
The present invention is not limited to the above-mentioned embodiments, and may also be used as a bioimplant such as an artificial ankle joint, an artificial shoulder joint, a bone screw, an artificial skull bone, and an in-vivo / intracorporeal opening member as a biometric terminal. You can

【0030】[0030]

【発明の効果】叙上のように本発明の生体インプラント
は所望部材がYAGセラミックスから構成されるので、 イットリアを含有しX線非透過性があるのでX線検査
によってインプラントの部位が明確に確認出来る、 YAGセラミックスであるので熱伝導率が小さく、周
囲の神経組織への刺激が小さい、 一般的なセラミックスの欠点である不透明性を無くせ
ば、術中の患部を透視できる、 加工性が高く、異型品の制作が容易である、 耐薬品性にすぐれている、といった多くの優れた効果
を奏するものである。
As described above, since the desired member of the bioimplant of the present invention is made of YAG ceramics, it contains yttria and is impermeable to X-rays, so the site of the implant can be clearly confirmed by X-ray inspection. Yes, because it is YAG ceramics, its thermal conductivity is low, and its stimulation to the surrounding nerve tissue is small. Without the opacity, which is a drawback of general ceramics, it is possible to see through the affected area during surgery. It has many excellent effects such as easy production of products and excellent chemical resistance.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明実施例の生体インプラントとしての人工
指関節の側面図である。
FIG. 1 is a side view of an artificial finger joint as a biological implant according to an embodiment of the present invention.

【図2】本発明実施例の生体インプラントとしての歯科
インプラントの側面図である。
FIG. 2 is a side view of a dental implant as a living body implant according to an embodiment of the present invention.

【符号の説明】[Explanation of symbols]

1 第1部材 2 第2部材 3 ジュイント部 F 人工指関節 D 歯科インプラント P ポスト部 S 歯根部 N ネジ溝 1 1st member 2 2nd member 3 Joint part F Artificial finger joint D Dental implant P Post part S Root part N Thread groove

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 イットリア・アルミニウム・ガーネット
の結晶を主体とするセラミックスにより構成した部材を
具備してなる生体インプラント。
1. A bioimplant comprising a member made of ceramics mainly composed of yttria aluminum garnet crystals.
【請求項2】 上記セラミックスの平均粒径が3〜10
0μm の範囲内であることを特徴とする請求項1の生体
インプラント。
2. The average particle size of the ceramic is 3 to 10
The bioimplant according to claim 1, which is in the range of 0 μm.
JP13355495A 1995-05-31 1995-05-31 Biological implant Expired - Fee Related JP3261009B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13355495A JP3261009B2 (en) 1995-05-31 1995-05-31 Biological implant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13355495A JP3261009B2 (en) 1995-05-31 1995-05-31 Biological implant

Publications (2)

Publication Number Publication Date
JPH08322926A true JPH08322926A (en) 1996-12-10
JP3261009B2 JP3261009B2 (en) 2002-02-25

Family

ID=15107531

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13355495A Expired - Fee Related JP3261009B2 (en) 1995-05-31 1995-05-31 Biological implant

Country Status (1)

Country Link
JP (1) JP3261009B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691765B2 (en) 2005-03-31 2010-04-06 Fujifilm Corporation Translucent material and manufacturing method of the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691765B2 (en) 2005-03-31 2010-04-06 Fujifilm Corporation Translucent material and manufacturing method of the same

Also Published As

Publication number Publication date
JP3261009B2 (en) 2002-02-25

Similar Documents

Publication Publication Date Title
DE3433210C1 (en) Means for filling bone and tooth defects, for bone building, for bone contact layers and for bone and tooth root replacement and use of carbonate apatite for this purpose
US20110195378A1 (en) Composite Bio-Ceramic Dental Implant and Fabricating Method Thereof
JP2010512902A (en) Metal oxide scaffolding
US20130150227A1 (en) Composite Bio-Ceramic Dental Implant and Fabricating Method Thereof
KR20160145473A (en) Dental implant made of zirconia ceramic-fused-bioactive glass ceramic artificial bone dust
CN103357063A (en) Metal composite material capable of inducing bone growth and application thereof
Kundu et al. Fabrication and characterization of porous hydroxyapatite ocular implant followed by an in vivo study in dogs
Desai et al. Metallic and ceramic biomaterials: current and future developments
RU2218895C1 (en) Contour plasty method and implant for restoring, correcting and removing or substituting defects, injuries or deformities of bone or cartilage tissue
Hench Prosthetic implant materials
Hossain et al. Recent development of dental implant materials, synthesis process, and failure–a review
TWI230058B (en) Hydroxylapatite powder, porous body and method for preparing thereof
Nurhidayat et al. Review of the temperature and holding time effects on hydroxyapatite fabrication from the natural sources
WO2020177382A1 (en) Treatment method for zirconium alloy and application
JPH08322926A (en) Bioimplant
RU28608U1 (en) CERAMIC ENDOPROTHESIS
Vlasov et al. Ceramics and medicine
RU25996U1 (en) IMPLANT FOR CONTOUR PLASTIC, RESTORATION, CORRECTION, ELIMINATION OR REPLACEMENT OF DEFECTS, DAMAGES OR DEFORMATIONS OF BONE OR CARTILAGE TISSUE
JPH0622572B2 (en) Zirconia implant material for living body
RU2705805C2 (en) Bone implant
KR102265093B1 (en) Mri compatible-high entropy alloys and implant comprising same
Raghavan et al. Bioceramics: dental implant biomaterials
Sridhar et al. Biomaterials corrosion
CN104446386B (en) Be used for aluminium oxide ceramics of hip joint and preparation method thereof
CN108610046A (en) A kind of glass bioceramic and preparation method thereof

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees